Results 91 to 100 of about 19,821,917 (190)

Guideline for the Comprehensive Perioperative Management of Older Patients With Lung Cancer (2025)

open access: yesJournal of Evidence-Based Medicine, EarlyView.
ABSTRACT With the accelerating population aging, the number of older adult patients with lung cancer continues to increase. These patients often present with multiple chronic diseases and geriatric syndromes, resulting in more complex perioperative management and significantly increased surgical risks.
Daiping Li   +6 more
wiley   +1 more source

Early use of non-vitamin K antagonist oral anticoagulants after cardiac surgery compared with warfarin for postoperative atrial fibrillation

open access: yes
Background The introduction of non-vitamin-K-antagonist oral anticoagulants (NOAC) has shifted the landscape of anticoagulation in the setting of atrial fibrillation (AF), as an alternative to warfarin.
Chang, S   +5 more
core   +1 more source

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

open access: yesItalian Journal of Medicine, 2013
standard dual antiplatelet therapy (DAPT) of aspirin and clopidogrel is associated with a substantial absolute incidence of adverse events, including death, myocardial infarction and stroke after an acute coronary syndrome (ACs).
Andrea Rubboli
doaj   +1 more source

The DOAC‐FRAIL Study—Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Direct oral anticoagulants (DOACs) are prescribed using fixed dosing regimens, despite limited evidence on their pharmacokinetic behavior in nursing home residents. Participants and Setting One hundred nursing home residents are receiving apixaban, rivaroxaban, dabigatran, or edoxaban in multiple long‐term care facilities in the ...
Irme S. Franssen   +11 more
wiley   +1 more source

Bibliometric Analysis of Non-Vitamin K Antagonist Oral Anticoagulants (NOACS) in the Prevention of Venous Thrombosis and Pulmonary Embolism [PDF]

open access: yes
Fangyi Zhou,1– 4 Zicheng Pang,1,4,5 Zhuoming Chen,6 Kai Hu,4,7 Jian Luo,1,4 Sihui Huang,8 Qiang Qu1,4 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People’s Republic of China; 2Teaching and Research Section
Huang S   +6 more
core  

Patients' adherence to oral anticoagulants therapy: Comparison between vitamin K antagonists and direct oral anticoagulants

open access: yes, 2021
Background: Patient's adherence to oral anticoagulant therapy is essential to prevent and treat thrombotic events. Methods: To assess the patients' adherence Morisky Medication Adherence Scale 8-items was used.
Perra F.   +7 more
core   +1 more source

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation

open access: yesJournal of Arrhythmia, 2017
Atrial fibrillation (AF) is the most common sustained arrhythmia, causing a 2-fold increase in mortality and a 5-fold increase in stroke. The Asian population is rapidly aging, and in 2050, the estimated population with AF will reach 72 million, of whom ...
Chern-En Chiang, MD, PhD   +8 more
doaj   +1 more source

Anticoagulation in sub-saharan africa with the advent of non-vitamin K antagonist oral anticoagulants

open access: yesNigerian Journal of Medicine, 2020
Background: Since the approval of warfarin, a Vitamin K antagonist anticoagulant (VKA), no other oral anticoagulant existed for patients who needed long‑term anticoagulation therapy until the recent introduction of non‑VKA oral anticoagulants (NOACs). NOACs came to fill in therapeutic gaps associated with VKA.
openaire   +3 more sources

Platelet‐Rich Fibrins as Local Drug‐Delivery Carriers

open access: yesJournal of Periodontal Research, EarlyView.
Autologous platelet concentrates (APCs), particularly platelet‐rich fibrin (PRF), act as biologically active fibrin scaffolds, capable of entrapping and gradually releasing therapeutic agents in oral and periodontal therapy. The incorporation of bioactive compounds, such as antibiotics, antifungals, vitamins, antidiabetic drugs, and exosomes, enhances ...
Karim M. Fawzy El‐Sayed   +1 more
wiley   +1 more source

Osteoporosis and Periodontitis: Two‐Way Epidemiological and Mechanistic Evidence

open access: yesJournal of Periodontal Research, EarlyView.
This review investigates the main mechanistic pathways connecting local periodontitis to systemic osteoporosis. Seven interconnected mechanisms are identified. ABSTRACT Osteoporosis and periodontitis are highly prevalent, chronic inflammatory diseases that constitute a major global health burden.
Jia Chang   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy